StemGen, Inc.
SGNI
$0.10
$0.06150.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | 33.33% | -- | -100.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 33.33% | -- | -100.00% | -- |
| Cost of Revenue | -17.65% | 124.56% | -- | -204.17% | 37.84% |
| Gross Profit | 17.65% | -22.58% | -- | -60.94% | -37.84% |
| SG&A Expenses | 350.15% | -25.96% | 146.79% | 87.18% | 940.63% |
| Depreciation & Amortization | -3.72% | 0.00% | 31.16% | 320.69% | 291.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 200.52% | -4.57% | 36.44% | 137.79% | 385.59% |
| Operating Income | -200.52% | 16.32% | -108.10% | -334.27% | -385.59% |
| Income Before Tax | -89.21% | 29.09% | -56.86% | -114.47% | -86.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -89.21% | 29.09% | -56.86% | -114.47% | -86.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -89.21% | 29.09% | -56.86% | -114.47% | -86.34% |
| EBIT | -200.52% | 16.32% | -108.10% | -334.27% | -385.59% |
| EBITDA | -300.26% | 27.03% | -141.38% | -370.15% | -277.45% |
| EPS Basic | -86.36% | 28.00% | -57.89% | -107.14% | -83.33% |
| Normalized Basic EPS | -123.08% | 8.33% | -58.33% | -100.00% | -85.71% |
| EPS Diluted | -86.36% | 28.00% | -57.89% | -107.14% | -83.33% |
| Normalized Diluted EPS | -123.08% | 8.33% | -58.33% | -100.00% | -85.71% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.01% | -0.08% | 0.53% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.01% | -0.08% | 0.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
